Author: Alexander Lee
Alexander Lee
Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.
CLEO, a renowned healthcare organization, has chosen several clinical trial sites located in the United States. These selected sites will be conducting important research studies aimed at advancing medical knowledge and improving patient care. The decision made by CLEO underscores the importance of the clinical trial sites’ expertise and capabilities in conducting high-quality research. This partnership will undoubtedly contribute to the development of cutting-edge medical treatments and therapies.
Westgold Resources Limited (ASX: WGX) (TSX: WGX) (OTCQX: WGXRF) has announced the expansion of its Bluebird – South Junction mining complex, with the South Junction mine becoming the primary ore source for the Bluebird processing hub in Meekatharra. The company aims to achieve a 1.2Mtpa run rate from Q3, FY25. The maiden Ore Reserve for the South Junction mine has been presented by Westgold, marking a significant milestone in the development of the mining complex. The South Junction mine is set to play a crucial role in supplying ore for processing at the Bluebird hub. Recent drilling activities at South…
In discussing the complexities of IgA nephropathy, Professor Dana Rizk, an Investigator and APPLAUSE-IgAN Steering Committee Member at the University of Alabama at Birmingham Division of Nephrology, highlights the evolving landscape of treatment options for this condition. IgA nephropathy, a rare and progressive disease characterized by kidney inflammation and proteinuria, affects approximately 25 individuals per million annually. Despite the current standard of care, up to 50% of patients with persistent proteinuria develop kidney failure within 10 to 20 years post-diagnosis, necessitating dialysis or transplantation. The Phase III APPLAUSE-IgAN study is evaluating the efficacy and safety of the oral medication Fabhalta…
On August 14, 2024, Aion Therapeutic Inc., a company based in Toronto, Ontario, announced that it will not be able to file its annual audited consolidated financial statements for the fiscal year ending April 30, 2024, along with other related documents, by the Filing Deadline of August 28, 2024. This delay is due to the acquisition of Toppen Health, Inc. on December 15, 2023, which requires valuation and impairment testing processes to be completed. As a result, the Company has requested a management cease trade order effective August 14, 2024. The Company expects to have the necessary filings completed and…
On August 14, 2024, Go Metals Corp., a company based in Vancouver, British Columbia, reported significant findings from a reconnaissance program conducted at the KM98 critical metals project located in Quebec, Canada. According to Scott Sheldon, the CEO of Go Metals, the company discovered multiple titanium-vanadium-bearing massive oxides occurrences at the project. The samples collected indicated medium to high-grade values in both vanadium and titanium, with some samples showing TiO2 values up to 48% and 0.37% V2O5. The geological team at Go Metals identified magnetite-rich zones at each target within the property. Further analysis revealed promising vanadium and titanium values,…
Melbourne, Victoria, Australia — A recent press release from Quantum Metal Sdn Bhd (Quantum) has highlighted the significant growth of Besra Gold Inc (ASX: BEZ) in the gold mining sector. Dato’ Lim Kong Soon, Chairman of Quantum and Besra, emphasized the company’s commitment to the preservation and growth of wealth through its expanding gold mining operations. The press release assured stakeholders that the gold ownership with Besra is guaranteed to be secure and profitable.
Northern Superior Resources (TSXV:SUP) has initiated a drilling campaign at the Philibert property in Quebec, with plans to conduct more than 20,000 meters of expansion drilling. The objective of the program is to extend mineralization along strike to the east and west, as well as along the hanging wall trend north and down dip of the open pit resource and defined pit. Located approximately nine kilometers from IAMGOLD’s (TSX:IMG) Nelligan project, the Philibert property has shown promising potential for gold exploration. Shares of Northern Superior Resources have seen an 8% increase to C$0.54 as of noon ET. The company has…
The Canadian junior mining sector has long been a cornerstone of the global resource industry, known for its significant contributions to mineral discoveries and economic development. As the world continues to demand critical minerals for technology, infrastructure, and energy, junior miners in Canada play an increasingly vital role in meeting these needs. This article explores the current state of the Canadian junior mining sector, highlighting the opportunities, challenges, and key companies to watch in 2024. The Backbone of Exploration in Canada Canada’s reputation as a mining powerhouse is built on the efforts of junior mining companies—small-cap firms focused on the…
OAKVILLE, ON, Aug. 15, 2024 – Nickel Creek Platinum Corp. (TSX: NCP) (OTCQB: NCPCF) (“Nickel Creek” or the “Company”) has received approval from the Toronto Stock Exchange (the “TSX”) and its Board of Directors has approved the consolidation of the issued and outstanding common shares of the Company. This consolidation was approved by shareholders at the annual general and special meeting held on June 25, 2024. The consolidation will be on the basis of one (1) new common share (a “Post-Consolidation Common Share”) for every 100 pre-consolidation outstanding common shares and will be effective on August 19, 2024 (the “Effective…
On August 16, 2024, PharmaCielo Ltd. (TSXV: PCLO) (OTC Pink: PCLOF) announced its financial results for the second quarter ended June 30, 2024. The company, a Canadian parent of PharmaCielo Colombia Holdings S.A.S., a premier cultivator and producer of dried flower and medicinal-grade cannabis extracts in Colombia, disclosed the following financial highlights for the second quarter: – Revenue: $784,000 – Adjusted EBITDA: $(592,000) – Net Loss: $(2,575,000) – Net Loss per Share: $(0.015) The company’s Chairman and CEO, Marc Lustig, highlighted the significant opportunities in the global cannabis market and emphasized PharmaCielo’s ability to cater to large consumer and pharmaceutical…